Position in GRFS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$14,609,769
-$10,533,316 QoQ
Shares Held
1,821,667
-32.3% QoQ
Ownership
0.268%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 89%
Shared 0%
None 11%
Common Shares in GRFS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HARRIS ASSOCIATES L P holds $1,552,520,428 across 3 Drug Manufacturers - General names.
All Filings in GRFS
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $14,609,769 | 1,821,667 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $25,143,085 | 2,689,100 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $27,221,676 | 2,733,100 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $28,258,136 | 3,125,900 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $24,451,290 | 3,439,000 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $27,705,816 | 3,723,900 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $34,256,376 | 3,857,700 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,342,087 | 3,857,700 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $25,769,436 | 3,857,700 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $31,861,672 | 2,756,200 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $25,284,896 | 2,766,400 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $25,370,452 | 2,769,700 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $20,574,092 | 2,791,600 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,890,900 | 2,575,400 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,734,416 | 1,742,600 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $13,401,828 | 1,128,100 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $10,530,688 | 901,600 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||